Literature DB >> 23403257

Gilbert and Crigler Najjar syndromes: an update of the UDP-glucuronosyltransferase 1A1 (UGT1A1) gene mutation database.

Giulia Canu1, Angelo Minucci, Cecilia Zuppi, Ettore Capoluongo.   

Abstract

UGT1A1 enzyme defects are responsible of both Gilbert syndrome (GS) and Crigler-Najjar syndrome (CNS). GS depends on a variant TATAA element (which contains two extra TA nucleotides as compared to the wild type genotype) in the UGT1A1 gene promoter resulting in a reduced gene expression. On the contrary, CNS forms are classified in two types depending on serum total bilirubin concentrations (STBC): the more severe (CNS-I) is characterized by high levels of STBC (342-684μmol/L), due to total deficiency of the UGT1A1 enzyme, while the milder one, namely CNS-II, is characterized by partial UGT1A1 deficiency with STBC ranging from 103 to 342μmol/L. GS and CNS are caused by genetic lesions involving a complex locus encoding the UGT1A1 gene. The present report provides an update of all reported UGT1A1 gene mutations associated to GS and CNS.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23403257     DOI: 10.1016/j.bcmd.2013.01.003

Source DB:  PubMed          Journal:  Blood Cells Mol Dis        ISSN: 1079-9796            Impact factor:   3.039


  27 in total

Review 1.  Uridine 5'-diphospho-glucronosyltrasferase: Its role in pharmacogenomics and human disease.

Authors:  Celia N Sanchez-Dominguez; Hugo L Gallardo-Blanco; Mauricio A Salinas-Santander; Rocio Ortiz-Lopez
Journal:  Exp Ther Med       Date:  2018-05-18       Impact factor: 2.447

2.  Clinical UGT1A1 Genetic Analysis in Pediatric Patients: Experience of a Reference Laboratory.

Authors:  Ann M Moyer; Jennifer M Skierka; Katrina E Kotzer; Michelle L Kluge; John L Black; Linnea M Baudhuin
Journal:  Mol Diagn Ther       Date:  2017-06       Impact factor: 4.074

Review 3.  Germline genetic variants with implications for disease risk and therapeutic outcomes.

Authors:  Amy L Pasternak; Kristen M Ward; Jasmine A Luzum; Vicki L Ellingrod; Daniel L Hertz
Journal:  Physiol Genomics       Date:  2017-09-08       Impact factor: 3.107

4.  Two unrelated patients with rare Crigler-Najjar syndrome type I: two novel mutations and a patient with loss of heterozygosity of UGT1A1 gene.

Authors:  Yan Li; Yu-jin Qu; Xue-mei Zhong; Yan-yan Cao; Li-min Jin; Jin-li Bai; Xin Ma; Yu-wei Jin; Hong Wang; Yan-ling Zhang; Fang Song
Journal:  J Zhejiang Univ Sci B       Date:  2014-05       Impact factor: 3.066

5.  Coupling AAV-mediated promoterless gene targeting to SaCas9 nuclease to efficiently correct liver metabolic diseases.

Authors:  Alessia De Caneva; Fabiola Porro; Giulia Bortolussi; Riccardo Sola; Michela Lisjak; Adi Barzel; Mauro Giacca; Mark A Kay; Kristian Vlahoviček; Lorena Zentilin; Andrés F Muro
Journal:  JCI Insight       Date:  2019-06-18

6.  UGT1A1 gene mutations and neonatal hyperbilirubinemia in Guangxi Heiyi Zhuang and Han populations.

Authors:  Xiao-Jing Wu; Dan-Ni Zhong; Xiang-Zhi Xie; De-Zhi Ye; Zong-Yan Gao
Journal:  Pediatr Res       Date:  2015-07-22       Impact factor: 3.756

7.  [A case of Gilbert syndrome caused by UGT1A1 gene compound heterozygous mutations].

Authors:  Weijie Ou; Su Lin; Yilong Wu; Yueyong Zhu
Journal:  Zhejiang Da Xue Xue Bao Yi Xue Ban       Date:  2020-05-25

Review 8.  Gene replacement therapy for genetic hepatocellular jaundice.

Authors:  Remco van Dijk; Ulrich Beuers; Piter J Bosma
Journal:  Clin Rev Allergy Immunol       Date:  2015-06       Impact factor: 8.667

Review 9.  Inherited disorders of bilirubin clearance.

Authors:  Naureen Memon; Barry I Weinberger; Thomas Hegyi; Lauren M Aleksunes
Journal:  Pediatr Res       Date:  2015-11-23       Impact factor: 3.756

10.  Genetic testing of UGT1A1 in the diagnosis of Gilbert syndrome: The discovery of seven novel variants in the Chinese population.

Authors:  Leilei Gu; Yue Han; Donghua Zhang; Qiming Gong; Xinxin Zhang
Journal:  Mol Genet Genomic Med       Date:  2022-04-14       Impact factor: 2.473

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.